Skip to content

Clinical trials

Completed Schizophrenia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Netherlands Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20051
20061
20072
20082
20091
20103
20112
20121
20131
20151
20162
20171
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UMC Utrecht4
AstraZeneca3
Eli Lilly and Company2
Hoffmann-La Roche2
Iris Sommer2
Janssen-Cilag International NV2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Amsterdam UMC, location VUmc1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia27
Psychotic Disorders10
Bipolar Disorder3
Mania2
Mental Disorders2
Anhedonia1
Autistic Disorder1
Bipolar and Related Disorders1
Hallucinations1
Inflammation1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.